4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-045234
Chief Business Officer bought 71,762 shares at $1.22 ($87,550)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hannah Brendan Chief Business Officer | 2023-08-08 | Purchase | +71,762 | $1.22 | $87,550 | 201,555 | D |
| Open-market purchases · 71,762 sh · avg $1.22 · $87,550 | |||||||
Loading xslF345X05/doc4.xml…